env gene diversity of HIV type 1 isolates from Spain

AIDS Research and Human Retroviruses

Volumn 12, Issue 10, 1996, Pages 955-957

  Quiñones Mateu, Miguel E ^a   Holguín, Africa ^a   Soriano, Vicente ^b   Domingo, Esteban ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

DRUG DESIGN; ENVELOPE GENE; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VACCINE PRODUCTION; VIRUS GENE; VIRUS ISOLATION;

EID: 0030059167     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.955     Document Type: Note

References (12)

1. Myers GM, Korber B, Berzofsky JA, Smith RF, and Paulakis GN: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1994.
2. Kostrikis L, Bagdades F, Cao Y, Zhang L, Dimitriou D, and Ho D: Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: Identification of a new subtype designated subtype I. J Virol 1995;69:6122-6130.
3. Soriano V, Gutierrez M, Gareia-Leima G, Aguilera O, Mas A, Bravo R, Perez-Labat M, Baquero M, and Gonzalez-Lahoz J: First case of HIV-1 group O infection in Spain. Vox Sang, 1996 (in press).
4. Nájera I, Holguin A, Quiñones-Mateu ME, Muñoz-Ferńandez MA, Nájera R, López-Galíndez C, and Domingo E: The pol gene quasispecies of human immunodeficiency virus. Mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol 1995;69:23-31.
5. Quiñones-Mateu ME, Holguin A, Dopazo J, Nájera I, and Domingo E: Point mutant frequencies in the pol gene of human immunodeficiency virus type 1 are two to three fold lower those than of env. AIDS Res Hum Retroviruses (in press).
6. Thompson JD, Higgins DG, and Gibson TJ: CLUSTALW: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
7. Felsenstein J: PHYLIP-Phylogeny inference package. Cladistics 1989;5:164-166.
8. Quiñones-Mateu ME, Dopazo J, Esté JA, Rota TR, and Domingo E: Molecular characterization of human immunodeficiency virus type 1 isolates from Venezuela. AIDS Res Hum Retroviruses 1995;11:605-616.
9. Kalish ML, Baldwin A, Raktham S, Wasi C, Luo C, Schochetman G, Mastro TD, Young N, Vanichseni S, Rübsamen-Waigmann H, von Briesen H, Mullins JI, Delwart E, Herring B, Esparza J, Heyward WL, and Osmanov S: The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: Implications for HIV vaccine trials. AIDS 1995;9:851-857.
10. Lukashov VV, Cornelissen MTE, Goudsmit J, Papuashvilli MN, Rytik PG, Khaitov RM, Karamov EV, and de Wolf F: Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia, and Lithuania. AIDS 1995;9:435-439.
11. Rojas JM, Dopazo J, Nájera I, Sánchez-Palomino S, Olivares I, Martin MJ, Bernal A, Garcia Saiz A, Nájera R, and López-Galindez C: Molecular epidemiology of HIV-1 in Madrid. Virus Res 1994;31:331-342.
12. Wilmot CM and Thornton JM: Analysis and prediction of the different types of β-turn in proteins. J Mol Biol 1994;203:221-232.